ArticleThrombosis journal2026

A post-marketing surveillance study on the safety and effectiveness of recombinant antithrombin gamma in patients with congenital antithrombin deficiency in Japan.

Hidesaku Asakura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.